Selective antagonism of medial prefrontal cortex D4 receptors decreases fear-related behaviour in rats

The European Journal of Neuroscience
Akeel A ShahDallas Treit

Abstract

It is well known that the mesolimbocortical dopamine pathway is highly active during periods of stress and fear. However, very little research has directly examined how dopamine receptors in this pathway influence fear-related behaviour. The present study examined the effects of selective antagonism of D(4), D(1) and D(2) dopamine receptors of the medial prefrontal cortex (MPFC) on rats' fear behaviour in the elevated plus-maze and the shock-probe burying tests. The results demonstrated that bilateral intra-MPFC infusions of the highly selective D(4) antagonist, L-745 870 (0.2, 1 or 10 nmol/0.5 microL), increased the percentage of open-arm entries and open-arm time in the elevated plus-maze test (1 nmol/0.5 microL), and decreased the duration of burying in the shock-probe test (0.2 or 1 nmol/0.5 microL). Furthermore, none of the doses of the D(4) antagonist affected measures of general activity or pain sensitivity. Intra-MPFC infusions of the D(1) antagonist, SCH-23390 (0.2 or 1 nmol/0.5 microL), or the D(2) antagonist, remoxipride (0.2, 1 or 10 nmol/0.5 microL), had no significant behavioural effects in either test. Taken together, these findings suggest that MPFC D(4) receptors may play an important role in the mediation of f...Continue Reading

References

Oct 1, 1981·Pharmacology, Biochemistry, and Behavior·D TreitH C Fibiger
Jan 1, 1984·Annals of the New York Academy of Sciences·R H Roth
Jul 1, 1994·Trends in Pharmacological Sciences·P Seeman, H H Van Tol
Oct 1, 1995·Pharmacology, Biochemistry, and Behavior·R J Rodgers, N J Johnson
Jun 1, 1997·Trends in Pharmacological Sciences·L J BristowG R Seabrook
Jun 1, 1995·Behavioural Pharmacology·L.M. BroersenB. Olivier
Feb 28, 2002·The European Journal of Neuroscience·Tomás L FalzoneMarcelo Rubinstein
Apr 15, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Philip M WallD Caroline Blanchard

❮ Previous
Next ❯

Citations

May 4, 2006·Psychopharmacology·Stan B Floresco, Orsolya Magyar
Aug 1, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jennifer R St Onge, Stan B Floresco
Jul 14, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stan B FlorescoMaric T L Tse
Aug 14, 2012·Pharmacology, Biochemistry, and Behavior·Mohammad Reza ZarrindastBatool Ghorbani Yekta
Oct 1, 2008·Behavioural Brain Research·Ofir PicazoMartha Garcia-Ramirez
Oct 13, 2009·Psychophysiology·Paul PauliKlaus Peter Lesch
Feb 18, 2006·Brain Research·Ron M Sullivan, Marc M Dufresne
May 14, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·R M SullivanF Laplante
Jul 5, 2011·Neuropharmacology·Michelle YeungClayton T Dickson
Jun 16, 2009·NeuroImage·Rajendra D BadgaiyanNathaniel M Alpert
Mar 1, 2011·Pharmacology, Biochemistry, and Behavior·Mohammad NasehiMohammad Reza Zarrindast
May 19, 2006·Neuroreport·Ulrich J Pfeiffer, Markus Fendt
Jan 19, 2019·Psychopharmacology·Christine StubbendorffCarl W Stevenson
Jul 7, 2021·Biochemistry. Biokhimii︠a︡·Konstantin N StupinElena A Rybnikova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.